Geuder supports CEPRECE eye clinic

Article

Geuder has announced its support for ophthalmic clinic CEPRECE, based in Cusco, Peru.

Geuder has announced its support for ophthalmic clinic CEPRECE, based in Cusco, Peru.

Up to 120 patients per day are treated in the South American clinic. Before it was not possible to treat retinal holes, retinal detachments, glaucoma and proliferative lesions.

Dr Frilo Silva, director of CEPRECE, was invited by Dr Berthold Seitz to attend a three-week crash course in modern laser techniques, phacoemulsification and vitrectomy.

The course included the use of the WetLab and Geuder's combined vitrectomy and phaco machine, as well as OR instruments. The German company joins a number of hospitals with the vision of transforming CEPRECE into a training centre for Peruvian ophthalmologists.

Ophthalmologists from Geuder were flown to Cusco to supervise the new OR techniques for Dr Silva.

To read more about Geuder's support for CEPRECE please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.